Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...

PHILADELPHIA (WPVI) -- Ten years is a significant milestone in any relationship. But it is especially monumental for one man and the medical device that helps keep him alive. Vince McCormack is one of ...

'Destination therapy' is a term that refers to the implantation of a left ventricular assist device (LVAD) with the aim of providing permanent circulatory support to people with advanced heart failure ...

The management of patients with end-stage heart failure or acute heart failure from naturally reversible causes is challenging; it may involve combination medical therapy (including inotropic support) ...

Two years ago, on a family skiing trip to Colorado, Toby Wise was struggling to keep up. Wise, 45, had always been in good health, played football in high school and played in a softball league and a ...

Every year, around 50,000 people in the United States experience cardiogenic shock - a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood ...

Too old and too sick for a heart transplant, Arvid Herrman was given a choice: Have a mechanical pump implanted in his heart, potentially keeping him alive for several years, or do nothing and almost ...

The meeting will feature sessions on AI in heart failure, advanced LVAD technologies, cardiac xenotransplantation, and more.